Published in

Elsevier, Fertility and Sterility, 1(87), p. 223-226, 2007

DOI: 10.1016/j.fertnstert.2006.06.019

Links

Tools

Export citation

Search in Google Scholar

Antimullerian hormone predicts ovarian responsiveness, but not embryo quality or pregnancy, after in vitro fertilization or intracyoplasmic sperm injection.

Journal article published in 2007 by J. M. J. Smeenk, C. G. J. Sweep, F. Sweep ORCID, G. A. Zielhuis, J. A. M. Kremer, C. M. G. Thomas, D. D. M. Braat
This paper was not found in any repository, but could be made available legally by the author.
This paper was not found in any repository, but could be made available legally by the author.

Full text: Unavailable

Green circle
Preprint: archiving allowed
Upload
Orange circle
Postprint: archiving restricted
Upload
Red circle
Published version: archiving forbidden
Policy details
Data provided by SHERPA/RoMEO

Abstract

Antimullerian hormone (AMH) and other markers of ovarian reserve were assessed to determine their predictive value with respect to treatment outcome. In a multivariate regression analysis, AMH was found to be predictive of the number of oocytes and the number of embryos, but not of embryo quality or the chance of a pregnancy, after IVF/ICSI.